IL51039A0 - Mixed polyol esters - Google Patents

Mixed polyol esters

Info

Publication number
IL51039A0
IL51039A0 IL51039A IL5103976A IL51039A0 IL 51039 A0 IL51039 A0 IL 51039A0 IL 51039 A IL51039 A IL 51039A IL 5103976 A IL5103976 A IL 5103976A IL 51039 A0 IL51039 A0 IL 51039A0
Authority
IL
Israel
Prior art keywords
polyol esters
mixed polyol
mixed
esters
polyol
Prior art date
Application number
IL51039A
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH17376A external-priority patent/CH616911A5/fr
Priority claimed from CH979076A external-priority patent/CH617175A5/en
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of IL51039A0 publication Critical patent/IL51039A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00Esters of sulfuric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
IL51039A 1976-01-08 1976-12-02 Mixed polyol esters IL51039A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH17376A CH616911A5 (en) 1976-01-08 1976-01-08
CH979076A CH617175A5 (en) 1976-07-30 1976-07-30 Processes for the preparation of mixed polyol esters

Publications (1)

Publication Number Publication Date
IL51039A0 true IL51039A0 (en) 1977-02-28

Family

ID=25683750

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51039A IL51039A0 (en) 1976-01-08 1976-12-02 Mixed polyol esters

Country Status (18)

Country Link
JP (1) JPS5285139A (en)
BG (1) BG27537A3 (en)
CA (1) CA1075708A (en)
DD (1) DD128400A5 (en)
DE (1) DE2654951A1 (en)
EG (1) EG12290A (en)
ES (1) ES453795A1 (en)
FI (1) FI763529A (en)
FR (1) FR2337552A1 (en)
GB (1) GB1572035A (en)
GR (1) GR61818B (en)
IL (1) IL51039A0 (en)
NL (1) NL7613457A (en)
PL (1) PL117246B1 (en)
PT (1) PT65894B (en)
RO (1) RO70355A (en)
SE (1) SE7613426L (en)
YU (1) YU286476A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL176551C (en) * 1979-04-25 1985-05-01 Shell Int Research PROCESS FOR PREPARING AN AROMATIC HYDROCARBON MIXTURE BY CATALYTIC CONVERSION OF A MIXTURE OF CARBON MONOXIDE AND HYDROGEN.

Also Published As

Publication number Publication date
CA1075708A (en) 1980-04-15
YU286476A (en) 1982-08-31
GR61818B (en) 1979-01-22
BG27537A3 (en) 1979-11-12
DE2654951A1 (en) 1977-07-21
PL194851A1 (en) 1979-05-07
PT65894A (en) 1976-12-01
GB1572035A (en) 1980-07-23
RO70355A (en) 1981-08-17
SE7613426L (en) 1977-07-09
ES453795A1 (en) 1978-01-16
PL117246B1 (en) 1981-07-31
FI763529A (en) 1977-07-09
NL7613457A (en) 1977-07-12
FR2337552A1 (en) 1977-08-05
PT65894B (en) 1978-05-18
DD128400A5 (en) 1977-11-16
EG12290A (en) 1979-06-30
JPS5285139A (en) 1977-07-15

Similar Documents

Publication Publication Date Title
GB1538632A (en) Polyester resin composition
JPS52148588A (en) Unsaturated polyester composition
JPS5339396A (en) Ever stabilized polyurethane
JPS5339395A (en) Ever stabilized polyurethane
JPS5312989A (en) Waterrhardenable mixture
JPS5242597A (en) Polyol mixture and polyurethane produced from same
GB1523530A (en) Tetrazole - 5-carboxylic acid esters
GB1537726A (en) Mixing
JPS539741A (en) Denatured polyol
AU2423177A (en) Esters
AU2985577A (en) N-chloroacetyl-n-phenyl-alanine esters
JPS52152496A (en) Crossslinked polyurethane
JPS5316961A (en) Ejector mixer
IL51039A0 (en) Mixed polyol esters
JPS52118475A (en) 44hydroxyy22quinolinonee33carboxyl ester
IL53136A (en) Polyester resin compositions
JPS52136264A (en) Mixing extruder
PT67412B (en) Esters
JPS5371092A (en) Spiramycine ester
BE848548A (en) MIXED POLYOL ESTERS
GB1555759A (en) Polyol compositions
JPS5321122A (en) Mixed alkylhydroge phosphate
ZA776737B (en) Novel esters
JPS5620020A (en) Polyol mixture
JPS5364865A (en) Innline mixer